Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations

被引:7
|
作者
Roujeau, Jean-Claude [1 ]
机构
[1] UPEC, Dept Dermatol, F-92160 Creteil, France
关键词
drug hypersensitivity; epidermal necrolysis; erythema multiforme; Stevens-Johnson syndrome; REGULATORY T-CELLS; ERYTHEMA MULTIFORME; INTRAVENOUS IMMUNOGLOBULIN; CUTANEOUS REACTIONS; LYELL SYNDROME; SKIN-LESIONS; HLA-B; CARBAMAZEPINE; DISEASE; DRUGS;
D O I
10.1016/j.dsi.2013.09.009
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To describe the history of toxic epidermal necrolysis, before and after the original report by the British dermatologist Alan Lyell in 1956. Methods: Subjective expert choice of key advances in the comprehension of the nosology, classification, causality, and mechanisms of epidermal necrolysis (EN) over more than a century. Results: Epidermolysis had been reported long before Lyell's paper, but most cases had likely been staphylococcal scalded skin syndrome in children. Concerning non-Staphylococcus EN, confusion with erythema multiforme dissipated and its relation to Stevens Johnson syndrome was clarified. Tremendous advances were made in understanding the causes and mechanisms, with increased acceleration in the last 10 years. Conclusion: The next decade should be devoted to improve the prevention and management of a disease that is the most terrible form of drug hypersensitivity. Copyright (C) 2013, Taiwanese Dermatological Association. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 50 条
  • [41] Insights on afatinib and toxic epidermal necrolysis/Stevens-Johnson syndrome
    Castellana, Eleonora
    Chiappetta, Maria Rachele
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2025,
  • [42] Pyroptosis of keratinocyte in Stevens-Johnson syndrome/toxic epidermal necrolysis
    Saito, Y.
    Hasegawa, A.
    Nishiguchi, T.
    Hama, N.
    Abe, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S71 - S71
  • [43] Stevens-Johnson syndrome/toxic epidermal necrolysis: a chronic condition?
    Lee, H. Y.
    Creamer, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (04) : 826 - 827
  • [44] The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
    Yang, Shang-Chen
    Hu, Sindy
    Zhang, Sheng-Zheng
    Huang, Jin-wen
    Zhang, Jing
    Ji, Chao
    Cheng, Bo
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [45] Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Ukponmwan, Catherine U.
    Njinaka, Itiyafe
    Ehimiyen, Efe T.
    TROPICAL DOCTOR, 2010, 40 (03) : 167 - 168
  • [46] Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies
    Wu, J.
    Lee, Y. Y.
    Su, S. C.
    Wu, T. S.
    Kao, K. C.
    Huang, C. C.
    Chang, W. C.
    Yang, C. H.
    Chung, W. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (05) : 1224 - 1231
  • [47] Allopurinol and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Foong, H. B. B.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (02): : 144 - 145
  • [48] Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Schneider, Jeremy A.
    Cohen, Philip R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : E117 - E117
  • [49] The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK
    Frey, Noel
    Jossi, Janine
    Bodmer, Michael
    Bircher, Andreas
    Jick, Susan
    Meier, Christoph
    Spoendlin, Julia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 290 - 291
  • [50] Recurrence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reply
    Finkelstein, Yaron
    Macdonald, Erin M.
    Juurlink, David N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (15): : 1591 - 1591